Thrombosis et diathesis haemorrhagica, 0340-6245

Tidskrift

Fler filtreringsmöjligheter
  1. A common origin of the 4143insA ADAMTS13 mutation

    Schneppenheim, R., Hovinga, J. A. K., Becker, J., Budde, U., Diana Karpman, Brockhaus, W., Hrachovinova, I., Korczowski, B., Oyen, F., Rittich, S., von Rosen, J., Tjonnfjord, G. E., Pimanda, J. E., Wienker, T. F. & Laemmle, B., 2006, I : Thrombosis and Haemostasis. 96, 1, s. 3-6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction

    Norlund, L., Johan Holm, Bengt Zöller & Öhlin, A-K., 1997 feb, I : Thrombosis and Haemostasis. 77, 2, s. 248-51

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators.

    Nilsson, M. E., Ole E Sørensen, Mörgelin, M., Weineisen, M., Sjöbring, U. & Heiko Herwald, 2006, I : Thrombosis and Haemostasis. 95, 6, s. 982-990

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Active but inoperable thrombin is accumulated in a plasma protein layer surrounding Streptococcus pyogenes.

    Naudin, C., Hurley, S., Erik Malmström, Plug, T., Oonagh Shannon, Meijers, J. C. M., Mörgelin, M., Lars Björck & Heiko Herwald, 2015, I : Thrombosis and Haemostasis. 114, 4, s. 717-726

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor

    Stanne, T. M., Olsson, M., Lorentzen, E., Pedersen, A., Gummesson, A., Gils, A., Jood, K., Gunnar Engström, Olle Melander, Declerck, P. J. & Jern, C., 2018, I : Thrombosis and Haemostasis. 118, 2, s. 298-308

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. A large deletion identified in a Swedish family with type 1 VWD

    Johansson, A. M., Lanke, E., Torbjörn Säll, Lethagen, S. & Halldén, C., 2011, I : Thrombosis and Haemostasis. 105, 4, s. 733-734

    Forskningsoutput: TidskriftsbidragLetter

  7. Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

    Somajo, S., Ahnström, J., Fernandez-Recio, J., Gierula, M., Villoutreix, B. O. & Björn Dahlbäck, 2015, I : Thrombosis and Haemostasis. 113, 5, s. 976-987

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Analytical considerations for free protein S assays in protein S deficiency

    Kristina Persson, Andreas Hillarp & Björn Dahlbäck, 2001, I : Thrombosis and Haemostasis. 86, 5, s. 1144-1147

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen

    Giri, T. K., Andreas Hillarp, Härdig, Y., Bengt Zöller & Björn Dahlbäck, 1998, I : Thrombosis and Haemostasis. 79, 4, s. 767-772 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis

    Norlund, L., Bengt Zöller & Öhlin, A-K., 1997 okt, I : Thrombosis and Haemostasis. 78, 4, s. 1164-1166 3 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Anti-inflammatory, anti-coagulant, anti-biotic?

    Heiko Herwald, 2013, I : Thrombosis and Haemostasis. 109, 4, s. 582-582

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  12. Antimicrobial activity of fibrinogen and fibrinogen-derived peptides - a novel link between coagulation and innate immunity.

    Lisa Påhlman, Mörgelin, M., Kasetty, G., Olin, A., Artur Schmidtchen & Heiko Herwald, 2013, I : Thrombosis and Haemostasis. 109, 5, s. 930-939

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis: A comparison with low molecular weight heparin

    J. Holst, Lindblad, B., Bergqvist, D., Nordfang, O., Ostergaard, P. B., Petersen, J. G. L., Nielsen, G. & Hedner, U., 1994, I : Thrombosis and Haemostasis. 71, 2, s. 214-219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Seron, M. V., Plug, T., Marquart, J. A., Marx, P. F., Heiko Herwald, de Groot, P. G. & Meijers, J. C. M., 2011, I : Thrombosis and Haemostasis. 106, 4, s. 609-616

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3.

    Kohler, S., Hallström, T., Singh, B., Kristian Riesbeck, Sparta, G., Zipfel, P. F. & Hammerschmidt, S., 2015, I : Thrombosis and Haemostasis. 113, 1, s. 125-142

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR

    Sandén, P., Renlund, H., Peter J. Svensson & Själander, A., 2017 jan 1, I : Thrombosis and Haemostasis. 117, 1, s. 27-32 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. BRCA2 gene mutations and coagulation-associated biomarkers

    Perez-Segura, P., Zamorano-León, J. J., Acosta, D., Santos-Sancho, J. M., Modrego, J., Caldés, T., De La Hoya, M., Díaz-Rubio, E., Díaz-Millán, I., De Las Heras, N., Zalba, L. A. R., Lahera, V., Olle Melander & Farré, A. L., 2016, I : Thrombosis and Haemostasis. 115, 2, s. 415-423 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10

    Strom, A. C., Cross, A. J., Cole, J. E., Blair, P. A., Leib, C., Goddard, M. E., Rosser, E. C., Park, I., Nilsson, A. H., Jan Nilsson, Mauri, C. & Monaco, C., 2015, I : Thrombosis and Haemostasis. 114, 4, s. 835-847

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.

    Lanke, E., Ann-Charlotte Kristoffersson, Philips, M., Lars Holmberg & Lethagen, S., 2008, I : Thrombosis and Haemostasis. 100, 2, s. 211-216

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

    David Erlinge, James, S., Duvvuru, S., Jakubowski, J. A., Wagner, H., Varenhorst, C., Tantry, U. S., Brown, P. B., Small, D., Moser, B. A., Sundseth, S., Walker, J. R., Winters, K. J. & Gurbel, P. A., 2014, I : Thrombosis and Haemostasis. 111, 5, s. 943-950

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Coagulation factorV and thrombophilia: Background and mechanisms

    Segers, K., Björn Dahlbäck & Nicolaes, G. A. F., 2007, I : Thrombosis and Haemostasis. 98, 3, s. 530-542

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

    Dickneite, G., Heiko Herwald, Korte, W., Allanore, Y., Denton, C. P. & Cerinic, M. M., 2015, I : Thrombosis and Haemostasis. 113, 4, s. 686-697

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  23. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls

    Emmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Andreas Hillarp & Reny, J-L., 2001, I : Thrombosis and Haemostasis. 86, 3, s. 809-816

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Control of smooth muscle cell proliferation - The role of the basement membrane

    Hedin, U., Roy, J., Tran, P. K., K. Lundmark & Rahman, A., 1999 dec 1, I : Thrombosis and Haemostasis. 82, SUPPL. 1, s. 23-26 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Diabetes duration may modify the association between genetic variation in the glycoprotein la subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis

    Reiner, AP., Elisabet Agardh, Teramura, G., Gaur, P., Gaur, LK. & Agardh, C-D., 2003, I : Thrombosis and Haemostasis. 89, 1, s. 142-148

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis

    Xiao Wang, Kristina Sundquist, Johan L. Elf, Strandberg, K., Peter J. Svensson, Hedelius, A., Palmér, K., Ashfaque A. Memon, Jan Sundquist & Bengt Zöller, 2016 aug 1, I : Thrombosis and Haemostasis. 116, 2, s. 328-336 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes

    Lethagen, S., Andreas Hillarp, Ekholm, C., Mattson, E., Halldén, C. & Britt Friberg, 2008, I : Thrombosis and Haemostasis. 99, 6, s. 1013-1018

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits

    Matthiasson, S. E., Lindblad, B., Mätzsch, T., Jan Holst & Bergqvist, D., 1994, I : Thrombosis and Haemostasis. 71, 3, s. 363-365

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers

    Mätzsch, T., Bergqvist, D., Hedner, U. & Ostergaard, P., 1987, I : Thrombosis and Haemostasis. 57, 1, s. 97-101

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats

    Mätzsch, T., Bergqvist, D., Hedner, U., Nilsson, B. & Ostergaard, P., 1990, I : Thrombosis and Haemostasis. 63, 3, s. 505-509

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Enhanced active metabolite generation and platelet inhibitionwith prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.

    Oscar Braun, Angiolillo, D. J., Ferreiro, J. L., Jakubowski, J. A., Winters, K. J., Effron, M. B., Duvvuru, S., Costigan, T. M., Sundseth, S., Walker, J. R., Saucedo, J. F., Kleiman, N. S. & Varenhorst, C., 2013, I : Thrombosis and Haemostasis. 110, 6, s. 1223-1231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin

    Jan Holst, Lindblad, B., Matthíasson, S. E., Stjernquist, U., Ezban, M., Østergaard, P. B. & Hedner, U., 1996 apr, I : Thrombosis and Haemostasis. 75, 4, s. 585-589

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Extracellular nucleic acids in immunity and cardiovascular responses: Between alert and disease

    Preissner, K. T. & Heiko Herwald, 2017, I : Thrombosis and Haemostasis. 117, 7, s. 1272-1282 11 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  34. Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man

    Hrafnkelsdottir, T., David Erlinge & Jern, S., 2001, I : Thrombosis and Haemostasis. 85, 5, s. 875-881

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. FactorVIIa and its potential therapeutic use in bleeding-associated pathologies

    Hedner, U., 2008, I : Thrombosis and Haemostasis. 100, 4, s. 557-562

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems

    Sen, P., Clark, C. A., Gopalakrishnan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, I : Thrombosis and Haemostasis. 107, 5, s. 951-961

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome

    Johan Holm, Andreas Hillarp, Bengt Zöller, Erhardt, L. RW., Erik Berntorp & Björn Dahlbäck, 1999, I : Thrombosis and Haemostasis. 81, 6, s. 857-860 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Family history of venous thromboembolism as a risk factor and genetic research tool.

    Bengt Zöller, Xinjun Li, Ohlsson, H., Jianguang Ji, Jan Sundquist & Kristina Sundquist, 2015, I : Thrombosis and Haemostasis. 114, 5, s. 890-900

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.

    Högberg, C., Olof Gidlöf, Deflorian, F., Jacobson, K. A., Abdelrahman, A., Müller, C. E., Björn Olde & David Erlinge, 2012, I : Thrombosis and Haemostasis. 108, 1, s. 119-132

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa